WallStreetZenWallStreetZen

NASDAQ: VRTX
Vertex Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Vertex Pharmaceuticals earnings were $3.6B for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest VRTX earnings report on Jun 30, 2025 announced Q2 2025 earnings of $1.0B, up 59.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VRTX reported annual earnings of -$535.6M, with -114.8% growth. The next VRTX earnings date is Oct 29, 2025.

VRTX past earnings growth

How has VRTX's earnings growth performed historically?

Company
N/A
Industry
31.31%
Market
29.69%
VRTX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
VRTX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

VRTX earnings history

Current Revenue
$11.4B
Current Earnings
$3.6B
Current Profit Margin
31.9%

VRTX Return on Equity

Current Company
22.1%
Current Industry
-9.6%
Current Market
31.7%
VRTX's Return on Equity (22.1%)... subscribe to Premium to read more.
High Return on Equity Performance

VRTX undefined

Current Company
15.9%
Current Industry
0%
VRTX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VRTX announces earnings.

VRTX undefined

Current Company
22.07%
Current Industry
7.7%
VRTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VRTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VRTX$4.59B$3.64B+11.98%$14.12
REGN$5.42B$4.46B+8.90%$41.76
ALNY-$192.50M-$319.09MN/A-$2.47
ARGX$811.30M$1.51BN/A$25.02
ONC$98.95M-$177.64MN/A-$0.13
View Top Biotech Stocks

VRTX earnings dates

Next earnings date
Oct 29, 2025

Vertex Pharmaceuticals Earnings Reports & History FAQ

What were Vertex Pharmaceuticals's earnings last quarter?

On VRTX's earnings call on Invalid Date, Vertex Pharmaceuticals (NASDAQ: VRTX) reported Q2 2025 earnings per share (EPS) of $4.02, up 128.88% year over year. Total VRTX earnings for the quarter were $1.03 billion. In the same quarter last year, Vertex Pharmaceuticals's earnings per share (EPS) was -$13.92.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.

When does Vertex Pharmaceuticals report earnings?

The next VRTX earnings date is Invalid Date. Add VRTX to your watchlist to be reminded of Vertex Pharmaceuticals's next earnings date.

Is Vertex Pharmaceuticals profitable or losing money?

As of the last Vertex Pharmaceuticals earnings report, Vertex Pharmaceuticals is currently profitable. Vertex Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $3.64 billion, a 842.52% decrease year over year.

What was VRTX's earnings growth in the past year?

As of Vertex Pharmaceuticals's earnings date in Invalid Date, Vertex Pharmaceuticals's earnings has grown year over year. VRTX earnings in the past year totalled $3.64 billion.

What are Vertex Pharmaceuticals's earnings expectations?

The current EPS estimate for Vertex Pharmaceuticals's earnings report in Invalid Date is $4.63.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.